LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Axsome Therapeutics (NASDAQ: AXSM)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ AXSM Axsome Therapeutics
Mahony Susan / director
02/21/2025
Buy
$137.75
1,312
$181K
1,312
NASDAQ AXSM Axsome Therapeutics
JEFFS ROGER / director
02/21/2025
Buy
$137.75
1,408
$194K
1,408
NASDAQ AXSM Axsome Therapeutics
Saad Mark E / director
02/21/2025
Buy
$137.75
1,494
$206K
1,494
NASDAQ AXSM Axsome Therapeutics
Maizel Ari / officer: Chief Commercial Officer
02/21/2025
Buy
$137.75
7,816
$1.077M
7,816
NASDAQ AXSM Axsome Therapeutics
Murdock Hunter R. / officer: General Counsel
02/21/2025
Buy
$137.75
7,816
$1.077M
7,816
NASDAQ AXSM Axsome Therapeutics
Pizzie Nick / officer: Chief Financial Officer
02/21/2025
Buy
$137.75
9,516
$1.311M
9,516
NASDAQ AXSM Axsome Therapeutics
Jacobson Mark L. / officer: Chief Operating Officer
02/21/2025
Buy
$137.75
10,875
$1.498M
10,875
NASDAQ AXSM Axsome Therapeutics
TABUTEAU HERRIOT / director, 10 percent owner, officer: Chief Executive Officer
02/21/2025
Buy
$137.75
28,887
$3.979M
28,887